GlassScriptPhysician profile
Timothy M Ruff
NPI 1629016753
$4,316.92
in general payments reported to CMS, 2019-2025
41 companies · $180 in 2025
The $180 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,885 · 2020: $114 · 2021: $710 · 2022: $622 · 2023: $611 · 2024: $196 · 2025: $180.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $986.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $985.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $1,397.13 | 2019 | |
| Novo Nordisk INC | $398.60 | 2020-2023 | Wegovy, Ozempic, Rybelsus |
| Organogenesis INC. | $305.50 | 2021-2025 | Puraply Am, Puraply Wound Matrix |
| Amgen INC. | $284.08 | 2020-2024 | Repatha, Otezla |
| Hologic INC | $176.92 | 2019-2022 | |
| Stryker Corporation | $148.85 | 2019 | |
| Genentech USA, INC. | $148.84 | 2019 | |
| Myriad Genetic Laboratories, INC. | $123.45 | 2021-2024 | Myrisk |
| Trevena, INC. | $123.11 | 2021-2022 | |
| Astrazeneca Pharmaceuticals LP | $105.40 | 2020-2024 | Farxiga |
| Amarin Pharma, INC. | $83.05 | 2020-2021 | |
| Nestle Healthcare Nutrition INC. | $77.16 | 2021-2023 | |
| Bayer Healthcare Pharmaceuticals INC. | $76.17 | 2021-2023 | |
| Smith+Nephew, INC. | $73.98 | 2019-2023 | Stravix Pl, Grafix Pl |
| Lilly USA, LLC | $70.65 | 2022-2023 | Emgality, Jardiance, Baqsimi |
Show all 41 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Integra Lifesciences Corporation | $63.73 | 2021 | |
| Janssen Pharmaceuticals, INC | $54.84 | 2022-2023 | Spravato, Xarelto |
| Medtronic, INC. | $53.02 | 2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $45.43 | 2023 | Xifaxan |
| Abbott Laboratories | $45.40 | 2022-2023 | Freestyle Libre 3 |
| Sumitomo Pharma America, INC. | $40.74 | 2023 | Gemtesa |
| Exact Sciences Corporation | $33.87 | 2023 | Cologuard Collection Kit |
| Ethicon US, LLC | $33.85 | 2025 | Vistaseal, Evarrest, Surgicel Nu-Knit |
| Lundbeck LLC | $32.45 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $31.21 | 2021-2022 | |
| Tactile Systems Technology INC | $27.48 | 2021-2022 | |
| Polynovo North America LLC | $26.32 | 2025 | Novosorb Btm |
| Ironshore Pharmaceuticals INC. | $23.31 | 2023 | Jornay Pm |
| Kerecis Limited | $22.40 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide, Kerecis Omega3 Marigen |
| Xeris Pharmaceuticals, INC. | $21.12 | 2023 | Keveyis |
| Glaxosmithkline, LLC. | $20.47 | 2021 | |
| Biogen, INC. | $20.23 | 2021 | |
| Olympus America INC. | $16.66 | 2019 | |
| Apria Healthcare LLC | $16.49 | 2021 | |
| Inspire Medical Systems, INC. | $15.37 | 2024 | Inspire |
| Abbvie INC. | $15.09 | 2023 | Creon, Linzess |
| Innocoll Pharmaceuticals Limited | $14.04 | 2021 | |
| Idorsia Pharmaceuticals US INC | $13.65 | 2023 | Quviviq |
| Neurocrine Biosciences, INC. | $13.51 | 2023 | Ingrezza, Ongentys |
| Lifenet Health | $11.92 | 2023 | |
| Vbi Vaccine (Delaware) INC. | $11.43 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Timothy Ruff listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.